Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
D000328:Adult; D000368:Aged; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001923:Brain Chemistry / Q000187:drug effects; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D010640:Phenothiazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D013747:Tetrabenazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D010640:Phenothiazines; D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents; D006220:Haloperidol; D004298:Dopamine; D013747:Tetrabenazine